VAL has been reported as a pro‐metastatic molecule, which is upregulated by aberrant AKT signaling in lung adenocarcinoma (LAD) and promotes LAD metastasis, suggesting that VAL is a promising marker for diagnosis and treatment of GCs.33 This evidence concerns the gene LINC01546 and leukocyte adhesion deficiency.